Depression and Inflammation in Patients With Coronary Heart Disease: Findings from the Heart and Soul Study

Biological Psychiatry

Volumn 62, Issue 4, 2007, Pages 314-320

  Whooley, Mary A ^a,b   Caska, Catherine M ^a   Hendrickson, Bethany E ^a   Rourke, Meghan A ^a   Ho, Joseph ^a   Ali, Sadia ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epidemiology; heart disease; inflammation; major depressive disorder

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; FIBRINOGEN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONFOUNDING VARIABLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; INTERVIEW; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; PRIORITY JOURNAL; VENOUS BLOOD;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CD40 LIGAND; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 34548855365     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.10.016     Document Type: Article

References (48)

1. Albert M.A., Danielson E., Rifai N., and Ridker P.M. Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. JAMA 286 (2001) 64-70
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (2000), American Psychiatric Association, Washington, DC Text Revision
3. Barth J., Schumacher M., and Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom Med 66 (2004) 802-813
4. Beattie M.S., Shlipak M.G., Liu H., Browner W.S., Schiller N.B., and Whooley M.A. C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: Data from the Heart and Soul Study. Circulation 107 (2003) 245-250
5. Carney R.M., Blumenthal J.A., Stein P.K., Watkins L., Catellier D., Berkman L.F., et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 104 (2001) 2024-2028
6. Danner M., Kasl S.V., Abramson J.L., and Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med 65 (2003) 347-356
7. Dentino A.N., Pieper C.F., Rao M.K., Currie M.S., Harris T., Blazer D.G., and Cohen H.J. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 47 (1999) 6-11
8. Dorland's Illustrated Medical Dictionary. 30th ed. (2003), Saunders, Philadelphia
9. Empana J.P., Sykes D.H., Luc G., Juhan-Vague I., Arveiler D., Ferrieres J., et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 111 (2005) 2299-2305
10. Evans D.L., Charney D.S., Lewis L., Golden R.N., Gorman J.M., Krishnan K.R., et al. Mood disorders in the medically ill: Scientific review and recommendations. Biol Psychiatry 58 (2005) 175-189
11. Folsom A.R., Qamhieh H.T., Flack J.M., Hilner J.E., Liu K., Howard B.V., and Tracy R.P. Plasma fibrinogen: Levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 138 (1993) 1023-1036
12. Ford D.E., and Erlinger T.P. Depression and C-reactive protein in US adults: Data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 164 (2004) 1010-1014
13. Gehi A.K., Rumsfeld J.S., Liu H., Schiller N.B., and Whooley M.A. Relation of self-reported angina pectoris to inducible myocardial ischemia in patients with known coronary artery disease: The Heart and Soul Study. Am J Cardiol 92 (2003) 705-707
14. Janszky I., Lekander M., Blom M., Georgiades A., and Ahnve S. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun 19 (2005) 555-563
15. Kop W.J., Gottdiener J.S., Tangen C.M., Fried L.P., McBurnie M.A., Walston J., et al. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 89 (2002) 419-424
16. Kroenke K., Spitzer R.L., and Williams J.B. The PHQ-9 validity of a brief depression severity measure. J Gen Intern Med 16 (2001) 606-613
17. Kuo H.K., Yen C.J., Chang C.H., Kuo C.K., Chen J.H., and Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: Systematic review and meta-analysis. Lancet Neurol 4 (2005) 371-380
18. Ladwig K.H., Marten-Mittag B., Lowel H., Doring A., and Koenig W. C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: Results from the MONICA-KORA Augsburg Cohort Study 1984-1998. Eur Heart J 26 (2005) 2537-2542
19. Lahlou-Laforet K., Alhenc-Gelas M., Pornin M., Bydlowski S., Seigneur E., Benetos A., et al. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Am J Cardiol 97 (2006) 1287-1291
20. Lesperance F., Frasure-Smith N., Theroux P., and Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 161 (2004) 271-277
21. Lett H.S., Blumenthal J.A., Babyak M.A., Sherwood A., Strauman T., Robins C., and Newman M.F. Depression as a risk factor for coronary artery disease: Evidence, mechanisms, and treatment. Psychosom Med 66 (2004) 305-315
22. Lubbock L.A., Goh A., Ali S., Ritchie J., and Whooley M.A. Relation of low socioeconomic status to C-reactive protein in patients with coronary heart disease (from the heart and soul study). Am J Cardiol 96 (2005) 1506-1511
23. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., and Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9 (1997) 853-858
24. Margaglione M., Grandone E., Mancini F.P., and Di Minno G. Drugs affecting plasma fibrinogen levels. Implications for new antithrombotic strategies. Prog Drug Res 46 (1996) 169-181
25. Matthies K.M., Newman J.L., Hodzic A., and Wingett D.G. Differential regulation of soluble and membrane CD40L proteins in T cells. Cell Immunol 241 (2006) 47-58
26. McAdams C., and Leonard B.E. Neutrophil and monocyte phagocytosis in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 17 (1993) 971-984
27. McManus D., Pipkin S.S., and Whooley M.A. Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol 96 (2005) 1076-1081
28. Miller G.E., Freedland K.E., Duntley S., and Carney R.M. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol 95 (2005) 317-321
29. Miller G.E., Stetler C.A., Carney R.M., Freedland K.E., and Banks W.A. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 90 (2002) 1279-1283
30. O'Toole M.T. Miller-Keane Encyclopedia & Dictionary of Medicine, Nursing, & Allied Health. 7th ed. (2003), Saunders, Philadelphia
31. Otte C., Marmar C.R., Pipkin S.S., Moos R., Browner W.S., and Whooley M.A. Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study. Biol Psychiatry 56 (2004) 241-247
32. Otte C., Neylan T.C., Pipkin S., Browner W.S., and Whooley M.A. Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: Findings from The Heart and Soul Study. Am J Psychiatry 162 (2005) 2139-2145
33. Panagiotakos D.B., Pitsavos C., Chrysohoou C., et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J 25 (2004) 492-499
34. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
35. Penninx B.W., Kritchevsky S.B., Yaffe K., Newman A.B., Simonsick E.M., Rubin S., et al. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 54 (2003) 566-572
36. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 27 (2006) 24-31
37. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
38. Robins L., Helzer J., Croughan J., and Ratcliff K. National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics, and validity. Arch Gen Psychiatry 38 (1981) 381-389
39. Rothermundt M., Arolt V., Peters M., Gutbrodt H., Fenker J., Kersting A., and Kirchner H. Inflammatory markers in major depression and melancholia. J Affect Disord 63 (2001) 93-102
40. Ruo B., Rumsfeld J.S., Hlatky M.A., Liu H., Browner W.S., and Whooley M.A. Depressive symptoms and health-related quality of life: The Heart and Soul Study. JAMA 290 (2003) 215-221
41. Schins A., Tulner D., Lousberg R., Kenis G., Delanghe J., Crijns H.J., et al. Inflammatory markers in depressed post-myocardial infarction patients. J Psychiatr Res 39 (2005) 137-144
42. Sluzewska A., Rybakowski J., Bosmans E., Sobieska M., Berghmans R., Maes M., and Wiktorowicz K. Indicators of immune activation in major depression. Psychiatry Res 64 (1996) 161-167
43. Spitzer R.L., Kroenke K., and Williams J.B. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282 (1999) 1737-1744
44. Stewart R.A., North F.M., West T.M., Sharples K.J., Simes R.J., Colquhoun D.M., et al. Depression and cardiovascular morbidity and mortality: Cause or consequence?. Eur Heart J 24 (2003) 2027-2037
45. Suarez E.C. C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med 66 (2004) 684-691
46. Tiemeier H., Hofman A., van Tuijl H.R., Kiliaan A.J., Meijer J., and Breteler M.M. Inflammatory proteins and depression in the elderly. Epidemiology 14 (2003) 103-107
47. van Melle J.P., de Jonge P., Spijkerman T.A., Tijssen J.G., Ormel J., van Veldhuisen D.J., et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosom Med 66 (2004) 814-822
48. Wells K.B., Hays R.D., Burnam M.A., Rogers W., Greenfield S., and Ware Jr. J. Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study. JAMA 262 (1989) 3298-3302